This particular presentation includes slide on basic virology about rabies virus, pathogenesis of rabies and it's management specially emphasized on guide of pre and post exposure vaccination.
3. Salient features of Rabies
Rabies is an acute infection of the CNS
Rabies is caused by rabies virus (Rabdoviridiae
family)
Transmission: Through saliva of infected animal
Mode of transmission: Animal bites, licks on
abrasion
Incubation period: 4 to 8 weeks (9-90 days)
Variation of incubation period: depends on site of
bite
Human is dead end host
4. Family: Rhabdoviridae
Genus: Lyssavirus
Shape: Rod or bullet shaped
Nucleocapsid: Helical
Genome: Single stranded RNA with negative
polarity, hence posses their own RNA
depended RNA polymerase. Replicates in cell
cytoplasm
Envelope: contains virus encoded
glycoproteins
The Virus
6. Antigenic properties of the virus
Single serotype
Antigenically different strains are prevalent in
various geographical location due to:
Epitopes difference in nucleoprotein
Epitopes difference in surface glycoprotein
7. The virus susceptibility to
environmental factors
Heat: 500 C for 1 hour
Ultraviolet light
Inactivated by CO2 (e.g., dry ice)
Chemicals: Ether, alcohol, detergents, trypsin
Extreme of pH
8. Animal susceptibility
VERY HIGH HIGH MODERATE LOW
Foxes,
Jackals,
Wolves,
Cotton rats
Hamster,
Cat, Bats,
Rabbit, Cattle
Dogs, Sheep,
Goats,
Horse, non-
human
primates
Opossums
11. Street virus versus Fixed virus
STREET VIRUS FIXED VIRUS
Freshly isolated from the
infected samples
Propagated in serial
passage in the rabbit brain
Variable incubation period
(21-60 days)
Fixed incubation period
(varies between 5-10 days
Inclusion bodies are
commonly formed
Not commonly formed
12. STREET VIRUS FIXED VIRUS
Wide host range Host range becomes
diminished
Extra-neuronal multiplication
occurs
Extra-neuronal multiplication
does not occur
Can not be used in vaccine Used in vaccine
Street virus versus Fixed virus
16. Pathology
Neuronal death and deyelination
Brain edema
Vascular congestion
Accumulation of inflammatory cells
(lymphocytes)
Presence of eosinophilic, cytoplasmic
inclusion body
17. Negri body & Perivascular infiltration of
lymphocytes
18. Susceptibility to infection and
incubation period depends on:
Host factors:
Age, genetic configuration, immune status,
degree of laceration, site of bite
Viral factors:
Viral strain
Amount of inoculum
19. Average incubation period:
1-3 months in human
Shorter among children than adults
Prodromal period(2-10 days)
Anorexia, nausea, sore throat, photophobia and
change in the sensation of skin at the bite site
Clinical presentation
20. Acute neurological phase (2-7 days)
Occurs 80% of the cases and is ‘Furious’ form
Nervousness, hallucination, bizarre behavior
Increase sympathetic activity:
Lacrimation pupillary dilatation, salivation
Hydrophobia: Due to painful spasm of throat
muscles
Aerophobia: breathing difficulty against blowing
air
Clinical presentation
22. Laboratory diagnosis
A. SPECIMEN
HUMAN:
Skin biopsy from hair line
Corneal and brain tissue impression
CSF and blood
Saliva
ANIMAL: Brain biopsy of dead animal
23. Laboratory diagnosis
MICROSCOPY: of skin biopsy and corneal smear
Rabies antigens by IF method
Negri body by giemsa stain
SEROLOGY: Detects viral antibody
Serum antibodies are detected by IF and Nt test
Vaccination induces antibody in serum but not in
CSF
24. Definitive diagnosis in brain and spinal cord
STRUCTURE:
Shape: Spherical and sharply demarcated
Size: 2-10 µm
Internal structure: Basophilic granules in
eosinophilic matrix
Contents: Sub-viral particles-viral nucleocapsids
Laboratory diagnosis (Negri
body)
25. VIRAL CULTURE and ISOLATION
Infected tissue material is inoculated into the mice
brain or hamster and mouse cell line
Viral growth is identified by Negri body, IF
Laboratory diagnosis
26. ANIMAL OBSERVATION:
All suspected animals should be sacrificed to
recover the virus from the brain tissue
1O days observation for otherwise apparently
healthy animals
Laboratory diagnosis
27. Management (Treatment)
ESTABLISHED CASE
Anti-Rabies serum( Immunoglobulin): high dose
Anti-convulsant and sedatives
Antibiotics: to prevent bacterial wound infection
Parenteral nutrition
28. Management (Vaccination)
PRE-EXPOSURE PROPHYLAXIS: Day 0,7,21 or 28
Booster dose may need to maintain the antibody
titer of 1:5
POSTEXPOSURE PROPHYLAXIS: Day 0,3,7,14
and 28
Wound cleaning with soup and water, DO NOT
STICH
Anti rabies Immunoglobulin and vaccine
Tetanus prophylaxis
29. CATEGORY I:
Touching or feeding animals, licking of intact
skin
CATEGORY II:
Nibbling of uncovered skin, minor scratch,
abrasions without bleeding, licks on broken
skin
CATEGORY III:
Single or multiple transdermal bites or
scratches, contamination of mucous
membrane with saliva, bites of bat
Types of exposures
30. Management according to category
CATEGORY I:
No treatment is required
CATEGORY II:
Only vaccination is required
CATEGORY III:
Vaccination and Immunoglobulin are required
Intramuscular administration of 1ml or 0.5 ml
HDCV preferably in deltoid region or
anterolateral aspect of thigh (in children)
31. Vaccine Candidate
Preexposure:
Rabies virus contacts: Research and laboratory
workers
Rabid animal contacts: Veterinarians, zoo
keepers
Postexposure: depends on
Nature of biting animal
Provocative or unprovocative bite
Severity of the bite
Availability of the animal
32. Types of vaccines
Human diploid cell vaccine (HDCV):
Virus grown in MRC-5 human diploid cell line
Virus is inactivated by β-propiolactone
Purified chick embryo cell vaccine(PCEC):
Grows in chicken fibroblast
Inactivated by β-propiolactone
Duck embryo vaccine
Nerve tissue vaccine: causes allergic
encephalomyelitis
33. REFERENCES
Jawetz, Melnick, Adelberg. Medical Microbiology. 25th
ed. Lange publication; 2010.
Kenneth J.R, C. George Ray, editors. Sherris Medical
Microbiology.4th edition. McGraw-Hill, Inc; 2004.
Alan L. Rothman. Current topics in Microbiology and
Immunology, vol 336: Springer-Verlag Berlin Heidelberg,
2010.
Nipah virus infection: WHO
33
Dr. Tarek/SSMC/2016 2/18/2018